A multicentre validation study of the diagnostic value of plasma neurofilament light
Cerebrospinal fluid neurofilament light (NfL) is a biomarker for neurodegeneration that can also be assessed in blood. Here the authors show in a validation study the potential for plasma NfL as a biomarker for several neurodegenerative diseases.
Guardado en:
Ejemplares similares
-
Plasma biomarkers of Alzheimer’s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations
por: Nicholas C. Cullen, et al.
Publicado: (2021) -
Targeting inflammation in depression: Ketamine as an anti-inflammatory antidepressant in psychiatric emergency
por: Naghmeh Nikkheslat
Publicado: (2021) -
Synaptic proteins in CSF relate to Parkinson’s disease stage markers
por: Erika Bereczki, et al.
Publicado: (2017) -
Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
por: Shorena Janelidze, et al.
Publicado: (2020) -
Personalism or party platform? Gender quotas and women's representation under different electoral system orientations.
por: Aliza Forman-Rabinovici, et al.
Publicado: (2021)